Search

Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.

… Thursday, May 9, 2013 Summary Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years. Christopher D. Lima , a structural biologist at Memorial Sloan Kettering,

A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.

… Thursday, July 29, 2021 Mesothelioma is a rare cancer that affects the lining surrounding organs, usually in the chest and abdomen. Treating this disease has been challenging because in most cases it is not possible to remove all the cancer with surgery. The FDA has approved only two new therapies since

When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat.

… Saturday, July 1, 2023 By Matt Tontonoz When Urvi Shah, MD , was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat. She thought, as a doctor who was training

MSK researchers identify mutations that convert nonthreatening thyroid tumors into aggressive cancers.

… Tuesday, August 8, 2017 Summary Most non-anaplastic thyroid cancers grow slowly and do not pose a threat. However, a small percentage become aggressive and spread quickly. Researchers have identified mutations that appear to turn these nonthreatening thyroid tumors into aggressive cancers. Highlights

Dr. Blinderman is a national leader in supportive care.

… Wednesday, November 1, 2023 Craig D. Blinderman, MD has been appointed Chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center (MSK). Dr. Blinderman is a national leader in supportive care who comes to MSK from Columbia University Medical Center/NewYork-Presbyterian Hospital, where

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.

… Monday, February 19, 2024 By the summer of 2022, Roberto Romero was running out of options to treat the melanoma he’d been coping with since 2015. He’d already had several surgeries and many rounds of drug treatment. But the cancer — which started as a dark spot under a toenail — continued to grow and

Learn whether eating soy products causes cancer.

… Wednesday, July 27, 2022 “Does eating soy cause breast cancer?” It’s a question regularly posed to Julia Brockway-Marchello , a Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist at MSK Nassau in Uniondale, New York. But her answer is a clear and decisive no. “Soy is actually helpful

Surprise! It has to do with metabolism.

… Wednesday, September 18, 2019 Summary The most commonly mutated gene in cancer,  p53, works by shifting cell metabolism in a way that alters a cell’s identity, researchers at the Sloan Kettering Institute have discovered. More than 50% of all cancers contain a mutation in the p53 gene. The protein made

Viviane Tabar, MD, has been named the new Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Tabar has been a vital faculty member at MSK for more than 15 years and is currently the Theresa C. Feng Chair for Neurosurgical Oncology and the Vice Chair for Neurosurgical Research and Education.

… Wednesday, December 6, 2017 Viviane Tabar, MD , has been named the new Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Tabar has been a vital faculty member at MSK for more than 15 years and is currently the Theresa C. Feng Chair for Neurosurgical Oncology

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Friday, October 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Luis Alberto Diaz, Jr. Appointed to the National Cancer Advisory Board by President Biden Luis Alberto Diaz, Jr. Luis Alberto Diaz, Jr., MD , Head of the Division of Solid Tumor Oncology